| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Potassium channel subfamily K member 2 | 0 | 2 | 4 | 6 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 15 | 0 | 0 | 15 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 24 | 0 | 0 | 24 |
| RAR-related orphan receptor gamma | 13 | 0 | 0 | 13 |
| USP1 protein, partial | 11 | 0 | 0 | 11 |
| Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
| aldehyde dehydrogenase 1 family, member A1 | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
| estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 15 | 0 | 0 | 15 |
| glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
| cytochrome P450 2D6 | 14 | 0 | 0 | 14 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| IDH1 | 7 | 0 | 0 | 7 |
| euchromatic histone-lysine N-methyltransferase 2 | 31 | 0 | 0 | 31 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 17 | 0 | 0 | 17 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
| mitogen-activated protein kinase 1 | 8 | 0 | 0 | 8 |
| geminin | 23 | 0 | 0 | 23 |
| peripheral myelin protein 22 | 12 | 0 | 0 | 12 |
| survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
| lethal factor (plasmid) | 7 | 0 | 0 | 7 |
| lamin isoform A-delta10 | 20 | 0 | 0 | 20 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 1 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 4 | 0 | 4 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 14 | 0 | 15 |
| ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 14 |
| G | 9 | 0 | 0 | 9 |
| Potassium voltage-gated channel subfamily KQT member 3 | 0 | 1 | 1 | 4 |
| Potassium voltage-gated channel subfamily KQT member 2 | 0 | 1 | 1 | 4 |
| Interferon beta | 10 | 0 | 0 | 10 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 2 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
| Alpha-2A adrenergic receptor | 0 | 4 | 2 | 7 |
| Adenosine receptor A3 | 0 | 7 | 1 | 8 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 3 | 7 |
| D(2) dopamine receptor | 0 | 3 | 1 | 4 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 4 |
| Cannabinoid receptor 1 | 0 | 4 | 0 | 5 |
| D(1A) dopamine receptor | 0 | 4 | 1 | 5 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 3 | 0 | 3 |
| C-X-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 3 | 1 | 4 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 5 | 1 | 6 |
| 5-hydroxytryptamine receptor 2C | 0 | 8 | 1 | 9 |
| Adenosine receptor A2a | 0 | 5 | 2 | 8 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 4 | 1 | 7 |
| Cholecystokinin receptor type A | 0 | 2 | 1 | 3 |
| C-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
| Cannabinoid receptor 2 | 0 | 4 | 1 | 6 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 2 | 4 |
| Mu-type opioid receptor | 0 | 3 | 1 | 5 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Delta-type opioid receptor | 0 | 3 | 1 | 5 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 3 | 1 | 4 |
| P2X purinoceptor 3 | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 12 | 0 | 12 |
| Sodium channel protein type 9 subunit alpha | 0 | 11 | 0 | 11 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 4 | 2 | 7 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| Sodium channel protein type 2 subunit alpha | 0 | 7 | 0 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 7 | 0 | 7 |
| P2X purinoceptor 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 6 | 0 | 6 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| GALC protein | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 14 | 0 | 0 | 14 |
| nuclear receptor subfamily 1, group I, member 3 | 13 | 0 | 0 | 13 |
| retinoic acid nuclear receptor alpha variant 1 | 11 | 0 | 0 | 11 |
| retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
| estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| arylsulfatase A | 10 | 0 | 0 | 10 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 13 | 0 | 0 | 13 |
| thyroid hormone receptor beta isoform a | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 13 | 0 | 0 | 13 |
| muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 11 | 4 | 2 | 17 |
| ATP-binding cassette sub-family C member 3 | 0 | 15 | 0 | 15 |
| Multidrug resistance-associated protein 4 | 0 | 15 | 0 | 16 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 4 | 1 | 10 |
| Prolyl endopeptidase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 25 | 0 | 25 |
| Glycogen phosphorylase, muscle form | 0 | 3 | 0 | 3 |
| Renin | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 1 | 0 | 8 | 1 | 19 |
| Carbonic anhydrase 2 | 0 | 8 | 1 | 18 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 5 | 0 | 5 |
| Carbonic anhydrase 3 | 0 | 4 | 1 | 10 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 7 | 0 | 8 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2D6 | 0 | 6 | 0 | 6 |
| Cytochrome P450 2A6 | 0 | 3 | 1 | 4 |
| Cytochrome P450 2C9 | 0 | 13 | 0 | 13 |
| 5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 11 | 4 | 2 | 17 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 11 | 4 | 2 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 11 | 4 | 3 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 11 | 4 | 2 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 11 | 4 | 2 | 17 |
| Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 1 | 3 |
| Carbonic anhydrase 4 | 0 | 6 | 1 | 11 |
| Carbonic anhydrase 6 | 0 | 5 | 1 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 11 | 4 | 2 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 11 | 4 | 2 | 17 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 1 | 4 | 0 | 8 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 11 | 4 | 2 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 11 | 4 | 2 | 17 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 11 | 4 | 2 | 17 |
| Adenosine receptor A2a | 0 | 5 | 0 | 9 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C19 | 0 | 5 | 0 | 5 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 1 | 10 |
| Carbonic anhydrase | 0 | 3 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Carbonic anhydrase 7 | 0 | 4 | 1 | 9 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 4 |
| D(2) dopamine receptor | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 11 | 4 | 3 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 11 | 4 | 2 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 11 | 4 | 3 | 18 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 1 | 3 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 7 | 3 | 13 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 5 | 1 | 11 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 5 |
| Carbonic anhydrase | 0 | 2 | 0 | 5 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 4 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 4 | 1 | 8 |
| GABA theta subunit | 11 | 4 | 2 | 17 |
| Canalicular multispecific organic anion transporter 1 | 0 | 15 | 0 | 15 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 6 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 3 | 0 | 7 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 11 | 4 | 2 | 17 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 4 | 1 | 10 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 4 | 1 | 10 |
| AR protein | 22 | 0 | 0 | 22 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 1 | 2 | 3 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| estrogen nuclear receptor alpha | 21 | 0 | 0 | 21 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
| Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Neutrophil cytosol factor 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor 2 | 9 | 5 | 2 | 17 |
| Nitric oxide synthase, endothelial | 0 | 2 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 2 | 0 | 3 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 2 | 1 | 5 |
| Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 7 | 0 | 0 | 7 |
| TDP1 protein | 21 | 0 | 0 | 21 |
| D(1A) dopamine receptor | 6 | 0 | 0 | 6 |
| neuropeptide S receptor isoform A | 7 | 0 | 0 | 7 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| phosphopantetheinyl transferase | 11 | 0 | 0 | 11 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| GLS protein | 16 | 0 | 0 | 16 |
| alpha-galactosidase | 4 | 0 | 0 | 4 |
| cytochrome P450 2C19 precursor | 6 | 0 | 0 | 6 |
| flap endonuclease 1 | 7 | 0 | 0 | 7 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
| Nitric oxide synthase, endothelial | 0 | 1 | 0 | 3 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 7 | 0 | 0 | 7 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| Luciferase | 6 | 0 | 0 | 6 |
| calpain II, partial | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 5 | 0 | 0 | 5 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| envelope glycoprotein | 0 | 1 | 0 | 1 |
| progesterone receptor | 8 | 0 | 0 | 8 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 11 | 0 | 0 | 11 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 8 | 0 | 0 | 8 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
| Histone H2A.x | 6 | 0 | 0 | 6 |
| cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
| perilipin-5 | 0 | 3 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| nuclear receptor corepressor 2 isoform 2 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 3 | 0 | 3 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| DNA polymerase beta | 5 | 0 | 0 | 5 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor gamma isoform 2 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 3 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Polymerase acidic protein | 0 | 1 | 1 | 2 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Alpha-1B adrenergic receptor | 0 | 8 | 1 | 9 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 4 | 1 | 6 |
| Alpha-synuclein | 2 | 1 | 1 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 1 | 9 |
| Alpha-1A adrenergic receptor | 0 | 8 | 1 | 9 |
| Histamine H2 receptor | 8 | 0 | 1 | 9 |
| Cytochrome P450 2J2 | 0 | 8 | 0 | 8 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 13 | 0 | 0 | 13 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 1 | 0 | 2 |
| Eyes absent homolog 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
| Eyes absent homolog 3 | 0 | 1 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 5 | 1 | 6 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| M17 leucyl aminopeptidase | 0 | 1 | 0 | 1 |
| M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Chain A, Chitinase | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 7 | 0 | 0 | 7 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| Cholinesterase | 0 | 3 | 0 | 3 |
| Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
| Amine oxidase [flavin-containing] A | 0 | 4 | 0 | 4 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Amine oxidase [flavin-containing] B | 0 | 5 | 0 | 5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 2 | 0 | 3 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 1 | 3 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 1 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 2 | 5 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A7 | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| N-acylethanolamine-hydrolyzing acid amidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Heat sensitive channel TRPV3 | 0 | 1 | 1 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 1 | 2 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 2 | 3 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 2 | 3 |
| G-protein coupled receptor 55 | 0 | 0 | 1 | 1 |
| Diacylglycerol lipase-alpha | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
| cytochrome P450 3A4 isoform 1 | 11 | 0 | 0 | 11 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 3 |
| Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 7 | 0 | 0 | 7 |
| Vpr | 2 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| Albumin | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 2 subunit alpha | 0 | 4 | 1 | 5 |
| Sodium channel protein type 3 subunit alpha | 0 | 5 | 0 | 5 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 1 | 3 |
| Sodium channel protein type 4 subunit alpha | 0 | 8 | 0 | 10 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Arginase | 0 | 2 | 0 | 2 |
| Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 2 | 3 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 1 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1B | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 7 | 0 | 0 | 7 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 6 | 0 | 0 | 6 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 11 | 1 | 22 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 2 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Relaxin receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| Nrf2 | 1 | 0 | 0 | 1 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| Smad3 | 4 | 0 | 0 | 4 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| toll-like receptor 9 | 0 | 1 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
| pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 3 | 0 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 4 | 0 | 0 | 4 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Prostaglandin E synthase | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 3 | 0 | 3 |
| Amyloid-beta precursor protein | 0 | 2 | 0 | 3 |
| Integrin beta-3 | 3 | 0 | 1 | 4 |
| Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 3 | 0 | 1 | 4 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Microtubule-associated protein tau | 0 | 2 | 0 | 3 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Heme oxygenase 2 | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 1 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 1 | 1 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
| Sortase A | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 3 | 0 | 3 |
| CREB-binding protein | 0 | 2 | 0 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 3 | 0 | 3 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
| Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 0 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 0 | 1 | 1 |
| Chain A, POLYMERASE PA | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Chain A, Polymerase Pa | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| galactokinase | 1 | 0 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Polycomb protein EED | 0 | 0 | 1 | 1 |
| NAD kinase | 0 | 2 | 1 | 3 |
| Dihydrofolate reductase | 0 | 0 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 0 | 1 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Hepatocyte growth factor receptor | 0 | 2 | 0 | 2 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Alpha-amylase 1A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 2 | 0 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| CPG DNA methylase | 0 | 1 | 0 | 1 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 0 | 1 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Signal transducer and activator of transcription 1-alpha/beta | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog | 0 | 2 | 0 | 2 |
| Fatty acid synthase | 0 | 2 | 0 | 2 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| BH3-interacting domain death agonist | 0 | 1 | 0 | 1 |
| Lactoperoxidase | 0 | 0 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] reductase | 0 | 1 | 0 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT2B | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 2 | 0 | 1 | 0 | 1 |
| Bcl2-associated agonist of cell death | 0 | 1 | 0 | 1 |
| Histone acetyltransferase KAT5 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B11 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B17 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 2 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 3 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B4 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2A1 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2A2 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 1 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 1 | 3 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 1 | 3 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A5 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 1 | 2 |
| UDP-glucuronosyltransferase 2B15 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 4 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2A3 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B28 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A7 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily KQT member 5 | 0 | 0 | 1 | 2 |
| Potassium voltage-gated channel subfamily KQT member 2 | 0 | 0 | 1 | 1 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 2 | 0 | 2 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 2 | 0 | 2 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 2 | 0 | 2 |
| fatty acid synthase | 0 | 1 | 0 | 1 |
| M-phase phosphoprotein 8 | 6 | 0 | 0 | 6 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Glutamate receptor 1 | 1 | 5 | 2 | 9 |
| Glutamate receptor 3 | 1 | 5 | 2 | 9 |
| Glutamate receptor 4 | 1 | 5 | 2 | 9 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 4 | 2 | 7 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 6 | 3 | 12 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 4 | 3 | 8 |
| Glutamate receptor 1 | 0 | 5 | 2 | 7 |
| Glutamate receptor 2 | 0 | 5 | 2 | 7 |
| Glutamate receptor 3 | 0 | 3 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 4 | 0 | 5 |
| Glutamate receptor 4 | 0 | 5 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 6 | 3 | 12 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 6 | 3 | 12 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 4 | 0 | 5 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 6 | 3 | 12 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 4 | 0 | 5 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 6 | 3 | 12 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 6 | 3 | 12 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 7 | 0 | 7 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 7 | 0 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 7 | 0 | 7 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 10 | 0 | 11 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 3 | 0 | 3 |
| regulator of G-protein signaling 4 | 9 | 0 | 0 | 9 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
| Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 4 | 0 | 0 | 4 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Excitatory amino acid transporter 4 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 4 | 0 | 4 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 3 | 2 | 5 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 2 | 4 |
| Excitatory amino acid transporter 1 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 2 | 0 | 2 | 0 | 3 |
| Excitatory amino acid transporter 3 | 0 | 2 | 0 | 3 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 3 | 2 | 5 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 4 | 0 | 5 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 4 | 0 | 0 | 4 |
| polyprotein | 4 | 0 | 0 | 4 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 8 subunit alpha | 0 | 4 | 0 | 4 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 3 | 6 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 6 | 4 | 11 |
| Beta-1 adrenergic receptor | 0 | 6 | 3 | 9 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 3 | 3 | 6 |
| Beta-1 adrenergic receptor | 0 | 5 | 3 | 10 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Alpha-1D adrenergic receptor | 0 | 0 | 2 | 3 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-1A adrenergic receptor | 0 | 1 | 3 | 5 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 4 | 7 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Chain C, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 2 | 8 |
| Sodium channel protein type 7 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 11 subunit alpha | 0 | 3 | 0 | 3 |
| Collagenase 3 | 0 | 1 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
| Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
| polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| ATP-binding cassette sub-family C member 9 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
| Albumin | 0 | 0 | 2 | 2 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 1 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Protein-serine O-palmitoleoyltransferase porcupine | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |